Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins: Myelodysplastic-Myeloproliferative Diseases trials
The registry lists 12 Myelodysplastic-Myeloproliferative Diseases studies with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 1 8Phase 2 2Phase 3 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaCompletedNCT00425477Phase 2Results posted
- Studying Fentanyl in Patients With CancerTerminatedNCT00899951
- Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative DisordersCompletedNCT00293410Phase 1
- Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerCompletedNCT00265837Phase 3
- Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic CancerCompletedNCT00255710Phase 1
- 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT00077558Phase 1
- MS-275 in Treating Patients With Hematologic CancerCompletedNCT00015925Phase 1
- Phenylbutyrate and Tretinoin in Treating Patients With Hematologic CancerCompletedNCT00006239Phase 1
- Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00006042Phase 1
- Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00004871Phase 1
- Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003961Phase 2
- Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic CancerCompletedNCT00003243Phase 1